中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
MeSH:(Iron Chelating Agents/*pharmacology)

1.Iron chelator daphnetin against Pneumocystis carinii in vitro.

Bin YE ; Yu-Qiang ZHENG ; Wei-Hua WU ; Jing ZHANG

Chinese Medical Journal 2004;117(11):1704-1708

2.Deferoxamine induces apoptosis of K562 cells.

Guo-Cun JIA ; You-Cai TANG ; Feng-Yi LI ; Qing-Kui LIAO

Chinese Journal of Contemporary Pediatrics 2011;13(8):674-676

3.Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci.

Choon Mee KIM ; Sung Heui SHIN

Journal of Korean Medical Science 2009;24(2):289-295

4.Detection of the labile iron pool in leukemia cells and its significance.

Guo-Cun JIA ; Ju GAO ; Qing-Kui LIAO ; Feng-Yi LI ; Li-Xing YUAN ; Bin HE

Journal of Experimental Hematology 2006;14(3):468-470

5.Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.

Dae Sik KIM ; Yoo Jin NA ; Myoung Hee KANG ; Soo Young YOON ; Chul Won CHOI

The Korean Journal of Internal Medicine 2016;31(2):357-366

6.Bacterial Growth in Amniotic Fluid Is Dependent on the Iron-Availability and the Activity of Bacterial Iron-Uptake System.

Young Joon AHN ; Sang Kee PARK ; Jae Wook OH ; Hui Yu SUN ; Sung Heui SHIN

Journal of Korean Medical Science 2004;19(3):333-340

7.Iron chelator inducesMIP-3alpha/CCL20 in human intestinal epithelial cells: implication for triggeringmucosal adaptive immunity.

Hyun Ju LEE ; Suck Chei CHOI ; Eun Young CHOI ; Moo Hyung LEE ; Geom Seog SEO ; Eun Cheol KIM ; Bong Joon YANG ; Myeung Su LEE ; Yong Il SHIN ; Kie In PARK ; Chang Duk JUN

Experimental & Molecular Medicine 2005;37(4):297-310

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO